The BCL-2 biomarker in the era of molecular diagnosis of diffuse large B-cell lymphoma.
Dunleavy
Kieron
K
Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Staudt
Louis M
LM
Wilson
Wyndham H
WH
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor / Q000032:analysis*; D019254:Genes, bcl-2; D006801:Humans; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D025202:Molecular Diagnostic Techniques; D011379:Prognosis; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D014408:Biomarkers, Tumor; D000069283:Rituximab